Neuroimaging, in particular magnetic resonance imaging (MRI), has been playing an
important role in understanding brain functionalities and its disorders during the last couple …

Background An increase in lifespan in our society is a double-edged sword that entails a
growing number of patients with neurocognitive disorders, Alzheimer's disease being the …

Early detection is critical for effective management of Alzheimer's disease (AD) and
screening for mild cognitive impairment (MCI) is common practice. Among several deep …

One of the first signs of Alzheimer's disease (AD) is mild cognitive impairment (MCI), in
which there are small variants of brain changes among the intermediate stages. Although …

Alzheimer's Disease (AD) is an irreversible neurodegenerative disease that results in a
progressive decline in cognitive abilities. Since AD starts several years before the onset of …

Alzheimer's disease (AD) is a neurodegenerative disease that affects brain cells, and mild
cognitive impairment (MCI) has been defined as the early phase that describes the onset of …

Early prediction of Alzheimer's disease (AD) is crucial for delaying its progression. As a
chronic disease, ignoring the temporal dimension of AD data affects the performance of a …

Predicting Alzheimer's disease (AD) progression is crucial for improving the management of
this chronic disease. Usually, data from AD patients are multimodal and time series in …

The classification of Alzheimer's disease (AD) using deep learning methods has shown
promising results, but successful application in clinical settings requires a combination of …

Introduction Multiple structural brain changes in Alzheimer's disease (AD) and mild cognitive
impairment (MCI) have been revealed on magnetic resonance imaging (MRI). There is a fast …